Cookies help us deliver our services. By using our services, you agree to our use of cookies. More information

Mitochondria-Targeted Drug Development

From Bioblast

high-resolution terminology - matching measurements at high-resolution

Mitochondria-Targeted Drug Development


Mitochondria-Targeted Drug Development

The Mitochondria-Targeted Drug Development Summit was first established in 2021, as an online conference. Due to its success and unmatched focus, the 2nd edition returns to Boston this March 2022. This is the only industry-led meeting that unites key stakeholders under a mutual and ambitious objective of accelerating the discovery and development of novel drugs that target mitochondrial functions for chronic, primary mitochondrial diseases, muscular dystrophy, metabolic disorders, and neurodegenerative diseases. Join our speakers from GenSight Biologics, Abliva, Reneo Pharma, Mito BioPharma, Mitokinin and more with exciting networking opportunities, panel discussions and dedicated roundtables.

Abbreviation: hansonwade

Reference: hansonwade

MitoPedia topics: MitoGlobal Organizations 


Contact details

T: (+1) 617 455 4188
E-mail: [email protected]

Conference address

Hyatt Regency Boston / Cambridge
575 Memorial Dr
MA 02139
United States


Listed as a MitoGlobal Society.

MitoGlobal         MitoEAGLE         MitoGlobal Societies         MiPsociety         ASMRM         MitoGlobal Events         MitoGlobal first